MYPROTOCOLSTACK
Knowledge BaseStart Free
Back to Knowledge Base
GH PEPTIDES8 min read·April 2026

Sermorelin vs Tesamorelin: Which GHRH Should You Use?

Sermorelin and tesamorelin are both GHRH analogs but they have meaningfully different pharmacology, IGF-1 response, and use cases. Here is how to choose.


Quick Summary - Both are GHRH analogs -- they stimulate the pituitary to release GH naturally rather than injecting GH directly - Tesamorelin is FDA-approved, has a longer half-life, and produces stronger IGF-1 response at equivalent doses - Sermorelin is gentler, lower cost, and preferred for older users or those new to GH optimization - Both require IGF-1 monitoring -- target 200-310 ng/mL - Tesamorelin is typically chosen for body composition and visceral fat reduction; sermorelin for general longevity and sleep quality

The Same Mechanism, Different Pharmacology

Sermorelin and tesamorelin are both synthetic GHRH (growth hormone-releasing hormone) analogs. They both work by binding to GHRH receptors in the pituitary gland and stimulating pulsatile GH release -- the same physiological pattern your body uses naturally.

This is the key distinction from direct GH injection: GHRH analogs preserve the pituitary feedback loop. Your body still regulates GH release. Somatostatin (the GH inhibitor) still applies the brakes when IGF-1 gets too high. You cannot chronically suppress your own GH production the way exogenous GH can.

But sermorelin and tesamorelin are not interchangeable. Their pharmacology differs in ways that make each a better choice for different situations.

Sermorelin: The Original, Gentler Option

Sermorelin is the oldest GHRH analog in clinical use, with decades of prescribing history and a well-established safety profile. It is the full 29-amino-acid sequence of naturally occurring GHRH.

Half-life: 10-20 minutes. Short and pulsatile -- very close to natural GHRH.

IGF-1 response: Moderate. At standard doses (200-500 mcg), most users see IGF-1 increases of 20-40% above baseline over 12 weeks.

Visceral fat reduction: Modest at standard doses. Less pronounced than tesamorelin.

Sleep quality: Consistently reported as one of sermorelin strongest effects -- users notice deeper sleep and more vivid dreams within 1-2 weeks, often before any body composition changes.

Who sermorelin is best for:

Users over 50 who want a gentle GH optimization approach
First-time GH peptide users -- lower risk of over-shooting IGF-1
Users primarily focused on sleep quality, recovery, and general longevity rather than aggressive body composition
Users where cost is a primary concern -- sermorelin is typically the most affordable GHRH analog

Standard sermorelin protocol:

Dose: 200-500 mcg subcutaneous
Timing: Bedtime, fasted 2-3 hours
Frequency: Daily or 5 days on, 2 days off

Tesamorelin: The FDA-Approved, Higher-Potency Option

Tesamorelin is a modified GHRH analog -- specifically, GHRH with a trans-3-hexenoic acid group added to improve stability and extend activity. It was FDA-approved in 2010 for HIV-associated lipodystrophy and has since become the most prescribed GHRH analog in longevity medicine.

Half-life: 26 minutes. Slightly longer than sermorelin, producing a more robust GH pulse per dose.

IGF-1 response: Strong. At 1-2 mg daily, most users see IGF-1 increases of 30-60% above baseline over 12 weeks. The absolute IGF-1 elevation is typically greater than sermorelin at comparable dosing windows.

Visceral fat reduction: Significant and well-documented -- this is tesamorelin FDA-approved indication and its most clinically validated effect. Users running 6-month cycles consistently show measurable VAT reduction by DEXA or imaging.

Body composition: Broader body composition effects than sermorelin -- more pronounced lean mass preservation, visceral fat reduction, and metabolic improvement.

Who tesamorelin is best for:

Users with meaningful visceral fat to reduce
Users who want the strongest IGF-1 response from a GHRH analog
Users running defined 3-6 month body composition cycles
Users who have already tried sermorelin and want to step up to stronger GH optimization

Standard tesamorelin protocol:

Dose: 1-2 mg subcutaneous
Timing: Bedtime, fasted 2-3 hours
Frequency: Daily or 5 days on, 2 days off for desensitization prevention

Key Lab Markers for Both

IGF-1: Primary efficacy marker. Baseline before starting, recheck at 6-8 weeks, recheck at 12 weeks. Target 200-310 ng/mL. Draw fasted, morning, 24+ hours post-dose.

Fasting glucose and HbA1c: GH can cause transient insulin resistance. Monitor at each draw. If fasting glucose rises above 95 or HbA1c approaches 5.7, consider dose reduction or adding berberine.

Cortisol: Chronic cortisol elevation blunts GH response. If IGF-1 is not responding to your protocol, check cortisol -- it may be explaining the inadequate response.

Thyroid (TSH, free T3, T4): GH axis optimization can unmask subclinical hypothyroidism. If you feel fatigued despite rising IGF-1, check thyroid.

Frequently Asked Questions

Can I stack sermorelin with ipamorelin?

Yes -- GHRH plus GHRP is the standard combination. Sermorelin plus ipamorelin is a common beginner stack that produces a synergistic GH pulse through two different receptor systems.

Can I stack tesamorelin with ipamorelin?

Yes. Tesamorelin plus ipamorelin is a more potent version of the same combination. This is typically reserved for users with more experience with GH optimization who want a robust response.

Should I cycle off GHRH analogs?

Most practitioners recommend 5 days on, 2 days off to prevent pituitary desensitization, or 3-6 month on cycles with 1-2 month off periods. Continuous daily use without breaks can lead to receptor downregulation over time.

Which is more expensive?

Sermorelin is typically the most affordable GHRH analog -- often 30-50% less expensive than tesamorelin per month from compounding pharmacies.

How do I know if my GH peptide is working without labs?

You do not -- not objectively. Subjective improvements in sleep, skin quality, and recovery are useful signals but not reliable measures of IGF-1 response. The only way to know your protocol is working at the biological level is to measure IGF-1.

The information in this article is for educational purposes only. It does not constitute medical advice. Always consult a licensed healthcare provider before starting any peptide protocol.

Written by Ryan -- Founder, MyProtocolStack. Last Updated: April 2026.

Track Your Labs. Build Your Protocol.

Enter your blood work in MyProtocolStack, run StackAI analysis, and get personalized insights based on your actual numbers -- not generic charts.

Start Free →
Not medical advice. Always consult a qualified healthcare provider before starting any peptide protocol. Read full disclaimer →
Related Articles
Tesamorelin & IGF-1: Tracking Real Results With Blood Work
7 min read read
Ipamorelin + CJC-1295 Stack: Dosing, Timing, and What to Expect from Your Labs
8 min read read
IGF-1 Blood Test: How to Read Your Results and What They Mean for Your Protocol
9 min read read
All Articles